Picture of Zhaoke Ophthalmology logo

6622 — Zhaoke Ophthalmology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Zhaoke Ophthalmology Says NMPA Granted Marketing Authorizations For Three Drugs

Dec 9 (Reuters) - Zhaoke Ophthalmology Ltd  6622.HK :
    * MARKETING AUTHORIZATIONS OBTAINED FROM NMPA FOR
LATANOPROST EYE
DROP, TRAVOPROST EYE DROP, AND TRAVOPROST TIMOLOL EYE DROP

Source text:  ID:nHKS2xwLZZ 
Further company coverage:  6622.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zhaoke Ophthalmology

See all news